蔚蓝生物：公司不存在生物可降解材料（如PHA）的业务布局或生物基单体的研发项目

Core Viewpoint - The company, Weilan Bio (603739.SH), has clarified that it does not have any business layout or research projects related to biodegradable materials (such as PHA) or bio-based monomers, despite the growing interest in synthetic biology technology platforms and government policies promoting bio-based materials development [1]. Group 1 - The company has identified "synthetic biology technology platform" as one of its core development directions in its 2024 annual report [1]. - The Ministry of Industry and Information Technology and five other departments have explicitly called for the promotion of research and industrialization of bio-based materials [1]. - The company has stated that it will strictly adhere to the disclosure obligations as per the Shanghai Stock Exchange listing rules and will provide relevant information through its periodic reports [1].